Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multikinase inhibitors and uses in prostatic hyperplasia and urinary track diseases

Multikinase inhibitors and uses in prostatic hyperplasia and urinary track diseases

US Patent 11376252 · Granted Jul 5, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-kinase inhibitors of VEGF and TGF beta and uses thereof2025
Multi-kinase inhibitors of VEGF and TGF beta and uses thereof2025
Pharmaceutical biodissolvable gels for drug delivery2025
Multikinase inhibitors of VEGF and TGF beta and uses thereof2024
Multikinase inhibitors of VEGF and TGF beta and uses thereof2024
Multikinase inhibitors and uses in reproductive and digestive tract fibrosis2022
Multikinase inhibitors and uses in reproductive and digestive tract fibrosis2022
Multikinase inhibitors and uses in reproductive and digestive tract fibrosis2022
Multikinase inhibitors and uses in ocular fibrosis2022
Multikinase inhibitors and uses in ocular fibrosis2022
Multikinase inhibitors and uses in ocular fibrosis2022
High viscosity macromolecular compositions for treating ocular conditions2021